Quoin Pharmaceuticals Ltd. (QNRX) stock
QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)
Close on Nov 18, 2026Market cap $7.15MP/E –Yield –
Quoin Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Quoin Pharmaceuticals's enterprise value was -$3.25M on Nov 11, 2026, against $10.96M a year earlier. Over the last 5 years it ranged from -$12.33M to $669.31B, with a median of $1.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.25M | -148.8% |
| 2025 | Dec 31, 2025 | $6.66M | +3832.6% |
| 2024 | Dec 31, 2024 | $169.26K | -89.9% |
| 2023 | Dec 29, 2023 | $1.68M | -100.0% |
| 2022 | Dec 30, 2022 | $412.96B | +285.7% |
| 2021 | Dec 31, 2021 | $107.07B | -63.1% |
| 2020 | Dec 31, 2020 | $290.44B | +67.2% |
| 2019 | Dec 31, 2019 | $173.70B | -78.8% |
| 2018 | Dec 31, 2018 | $820.28B | -63.7% |
| 2017 | Dec 29, 2017 | $2.26T | +227.2% |
| 2016 | Dec 30, 2016 | $690.45B | – |
See a number that looks wrong?